The study evaluates the association between methamphetamine use and cardiac disease among PWH.
This study examined clinic leadership and provider perceptions of factors associated with statin prescribing for persons with HIV receiving care in eight community health clinics across Los Angeles, California.
Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation
The article investigated compositional changes in the gut microbiome and its role in chronic inflammation in patients infected with HIV.
Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes
The study explores the long-term effects of cART on markers of gut damage, microbial translocation, and paired gut/blood microbiota composition, with a focus on the role exerted by different drug classes.
Altered gut microbiota correlates with different immune responses to HAART in HIV-infected individuals
Gut microbiota and immune activation were studied in 36 non-HIV-infected subjects and 58 HIV-infected individuals, including 28 immunological responders and 30 immunological non-responders without comorbidities.
Echocardiographic Findings Among Virally Suppressed HIV-Infected Aging Asians Compared with HIV-Negative Individuals
The study looked into the prevalence and risk factors associated with echocardiogram abnormalities among those who are older and living with HIV.
Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy
The study aimed to determine the relationship between oral and gut microbiome diversity and chronic systemic inflammation in ART-treated PLWH with prevalent severe periodontitis, an inflammatory condition commonly associated with HIV infection.
The last 15 years have witnessed a dramatic change in HIV-related epidemiology amidst improvements in treatment and care in China. With proper treatment, HIV is now considered a chronic disease. As a consequence, many people living with HIV (PLWH) now present age-related comorbidities. Thirteen topical issues were reviewed concerning the epidemiology of aging with HIV in mainland China.
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
Co-morbidities and multi-morbidities are extremely prevalent in people living with HIV. More than 50% of PLHW were multi-morbid and about 30% had three or more comorbidities. Those living with HIV are much more at risk of dying or living with more than one disease.
Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy
The study looked at 16S rDNA-based pyrosequencing to compare the salivary microbiome in three groups: (1) Chronically HIV-infected women >50 years of age (aging); (2) HIV-infected women <35 years of age (young adult); and (3) HIV-uninfected age-matched women.